NCT01461967View on ClinicalTrials.gov

A Study on Safety, Pharmacokinetics and Pharmacodynamics of RO5508887 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Healthy Volunteer
Interventions
DRUG

Placebo

Single ascending doses

DRUG

RO5508887

Single ascending doses

DRUG

RO5508887

Single doses

Trial Locations (1)

67064

Strasbourg

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01461967 - A Study on Safety, Pharmacokinetics and Pharmacodynamics of RO5508887 in Healthy Volunteers | Biotech Hunter | Biotech Hunter